CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities of $100.00 thousand for the 3-month period ending 2022-06-25, per its 10-Q filed 2022-08-03.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2022-08-03
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, increase resulting from settlements with taxing authorities for the quarter ending 2022-06-25 was $100.00K, a 95.24% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, increase resulting from settlements with taxing authorities for the quarter ending 2022-03-26 was $1.10M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, increase resulting from settlements with taxing authorities for the quarter ending 2021-09-25 was $1.20M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, increase resulting from settlements with taxing authorities for the quarter ending 2021-06-26 was $2.10M.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities 3 month | Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities 6 month |
|---|---|---|
| 2022-06-25 | $100.00K 10-Q · filed 2022-08-03 | $1.20M derived: sum of 2 quarters · filed 2022-08-03 |
| 2022-03-26 | $1.10M 10-Q · filed 2022-05-04 | |
| 2021-09-25 | $1.20M 10-Q · filed 2021-11-03 | $3.30M derived: sum of 2 quarters · filed 2021-11-03 |
| 2021-06-26 | $2.10M 10-Q · filed 2021-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |